@article{dd8c421feb524594b43581a49f860d34,
title = "Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting",
abstract = "Uveal Melanoma (UM) is the most common primary intra-ocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on {"}Outcome Measures of New Technologies in Uveal Melanoma{"}, addressing the latest advances in UM, starting with genetic developments, then moving on to imaging and treatment of the primary tumor, as well as to investigating the most recent developments in treating metastases, and eventually taking care of the patient's wellbeing. This review highlights the meeting's presentations in the context of the published literature.",
keywords = "Adult, Group Processes, Humans, Melanoma/diagnosis, Outcome Assessment, Health Care, Uveal Neoplasms/diagnosis",
author = "Beenakker, {Jan-Willem M} and Brouwer, {Niels J} and Cindy Chau and Coupland, {Sarah E} and Miltiadis Fiorentzis and Heinrich Heimann and Jens Heufelder and Joussen, {Antonia M} and Kiilgaard, {Jens F} and Kivel{\"a}, {Tero T} and Sophie Piperno-Neumann and Rantala, {Elina S} and Bozena Romanovska-Dixon and Shields, {Carol L} and Willerding, {Gregor D} and Thomas Wheeler-Schilling and Scholl, {Hendrik P N} and Jager, {Martine J} and Damato, {Bertil E}",
note = "The Author(s). Published by S. Karger AG, Basel.",
year = "2023",
doi = "10.1159/000524372",
language = "English",
volume = "66",
pages = "14--26",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",
number = "1",
}